Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New Biological Therapy Ilaris(R) Approved In US To Treat Children And Adults With CAPS, A Serious Life-Long Auto-Inflammatory Disease
The U.S. Food and Drug Administration (FDA) has approved Ilaris(R) (canakinumab) for the treatment of children and adults with cryopyrin-associated periodic syndrome (CAPS), which includes a number of rare, but life-long, auto-inflammatory disorders with debilitating symptoms and limited treatment options. The FDA granted priority review to Ilaris based on its potential to meet an important clinical need for patients with CAPS.

North Carolina State University And The University Of Strasbourg Agree To Collaborate On A Training Program
Strasbourg University and North Carolina State University, both leading academic institutions in the field of bioproduction, have entered into an agreement to collaborate on a unique set of training capabilities for industry. The Alsace Biovalley cluster has played and will continue to play a key role in the program by bringing together industry players in support of the project, ensuring that training programs meet industry needs, structuring the financial engineering required and securing funding for the infrastructures.
News of the day
Wyeth Presents New Analyses Of Data From Three Studies Of ENBREL(R) At The European League Against Rheumatism (EULAR) Annual Meeting
Analyses of data from three studies provide insight into the use of ENBREL®(etanercept) in the treatment of three conditions for which ENBREL is indicated: moderate-to-severe rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS). These analyses, presented this week during the European League Against Rheumatism (EULAR) Annual Meeting in Copenhagen, add to the body of evidence that supports treatment with ENBREL for patients with these conditions.
Oncology

Cosmetic Ear Surgery Has The Youngest Age Of Patients, Survey Finds

So many classic childhood movies (Dumbo) and sing-a-longs (Do your ears hang low? Do they wobble to and fro?) emphasize large and protruding ears. But it turns out that having protruding ears is often-times a humiliating feature for a teenager. According to the American Academy of Cosmetic Surgery"s 2008 Procedural Survey, 27.7% of otoplasties - a reshaping of the ear by placing small incisions behind the ear then reshaping or trimming the cartilage to define how and where the ear bends - are performed on those ages 13-19. Additionally, the survey found that otoplasty has the youngest mean age of both invasive and less invasive cosmetic procedures at 29. "While cosmetic surgery is not for all adolescents, there appears to be a trend in otoplasty for younger patients," states Dr. Patrick McMenamin, MD, President of the AACS. "The bottom line is that if the teen is of appropriate psychological and physical maturity, then the teen can reap the benefits of an early age otoplasty. In my experience, it is the youngster who comes in adamantly requesting the procedure." Generally, ears reach their full growth potential by age 6 which is drastically earlier than other parts of an adolescent body. In fact, it is preferred to have an otoplasty at a younger age because the cartilage is extremely flexible, thereby permitting greater ease of shaping and a better result. Sarah Massier American Academy of Cosmetic Surgery


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009